3,000 job losses to help AZ maintain profits and invest in R&D
February 9, 2007Sales and Marketing AZ
AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …
Momentum growing at specialists Archimedes as lead enters phase III
February 9, 2007Research and Development
Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …
Go-ahead for free prescriptions in Wales despite warnings
February 9, 2007Sales and Marketing NHS, Wales
Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …
Arrow purchase adds another string to AZ’s biotech bow
February 9, 2007Research and Development
AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …
Novartis set for ‘unprecedented’ wave of launches
February 9, 2007Sales and Marketing
Novartis is preparing to set a new record for the pharmaceutical industry by launching eight products in the next 12 …
50% drop in UK sales positions reveals fast-changing industry
February 9, 2007Sales and Marketing
Newly released figures show the number of sales representatives taking the ABPI exam dropped 50% in 2006; clear proof that …
Adventis expands into med ed with LeapFrog acquisition
February 8, 2007Medical Communications
Marketing communications group Adventis has acquired med ed agency LeapFrog Medical for more than £2 million to form one of …
Fast-growing Roche leads pharma sector
February 7, 2007Sales and Marketing
Roche has unveiled record-breaking profits for 2006, driven by pharma sales that grew by more than three times the market …
The evolution of the NHS in 2007
February 5, 2007Sales and Marketing NHS, sales, strategy
The NHS will undergo major reorganisation in 2007, just as it has in the nine preceding years of Labour's tenure. …
GPs praised for dramatic fall in unnecessary referrals
January 31, 2007The government has hailed the success of one of its key reforms, practice-based commissioning, saying it has helped some areas …
MorphoSys opens UK headquarters in Oxford
January 31, 2007Research and Development
A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …
Charity to help patients fight on for bowel cancer drugs
January 29, 2007NICE's decision not to recommend bowel cancer drugs on the NHS has left campaigners in fighting mood.The institute says Roche's …
Pharma’s eastern promise
January 29, 2007Sales and Marketing China, India
Thanks to spiralling costs, increasing regulation and the ever-present threat of litigious action, it is hardly surprising that pharma companies …
More than 250 UK jobs axed as Pfizer downsizes
January 26, 2007Sales and Marketing
Pfizer's UK salesforce is likely to be in the front line following the company's decision to slash more than 250 …
Packer Forbes scoops GSK Tycerb account
January 26, 2007Medical Communications GSK, Packer Forbest
London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …
Patient experience survey is discredited says BMA
January 26, 2007A row is brewing between doctors and the Department of Health over a major survey aimed at gauging patients' experiences …
Lucentis approved in Europe
January 26, 2007Sales and Marketing Lucentis, Novartis
European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …
Januvia set for EU approval
January 26, 2007Sales and Marketing
Januvia, the first in a new class of diabetes treatments, is set for approval in the European Union.Marketed by Merck …
Merck Serono picks Huntsworth for infertility work
January 26, 2007Medical Communications Huntsworth
Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs.The agency …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Latest content
FibroFind appoints Lee Borthwick as CEO
